Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.businesswire.com/news/home/20221210005002/en/Orca-Bio-Presents-Data-Demonstrating-its-Lead-Investigational-High-Precision-Cell-Therapy-Orca-T-Significantly-Improved-Relapse-Free-Survival-at-64th-ASH-Annual-Meeting
0
0
Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting - Business Wire
+ 130 more
12/10/22 at 8:00pm
Organization
Business Wire
Authors
Details
49 words
Summarize
Business & Industrial
Health Foundations & Medical Research
Orca Bio Presents Data Demonstrating its Lead Investigational High
Orca Bio
BUSINESS WIRE
American Society of Hematology Annual Meeting
Orca-T
Orca Bio today presented updated positive clinical data on Orca-T during an oral presentation at the American Society of Hematology Annual Meeting.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...